The GLP-1 Effect: How Weight-Loss Drugs Are Changing the Business of Healthcare
America's GLP-1 boom is reshaping healthcare. SHARx co-founder Paul Pruitt explains who pays, why costs are surging, and what comes next.
More Videos
The Next Healthcare Crisis? Drug Prices, Access and Medicare Face New Pressure
Healthcare policy is shifting fast, raising questions about drug prices, Medicare and access. Leap Health CEO Hani Elias explains what patients need to know.
Employers Are Pulling Back. What It Means for Your Next Job
The U.S. job market is cooling as hiring slows and employers turn cautious. LinkedIn’s Kory Kantenga breaks down jobs, wages, spending and AI’s impact.
S’Mores Are Having a Major Summer Moment: Hershey’s Is Turning Nostalgia Into Big Business
Hershey’s is turning s’mores into a $250M summer opportunity. Susanne Prucha, VP of CMG Marketing, reveals the strategy behind the sweet growth.
Appian CEO on AI’s Next Phase: From Hype to Real-World Results
AI is entering a new phase as enterprises move beyond experimentation and demand measurable returns. Appian CEO Matt Calkins discusses what comes next.
Why This 111-Year-Old Steel Company Is Making a $2.5 Billion Bet on Construction
Commercial Metals CEO Peter Matt reveals how a $2.5B acquisition spree is transforming the 111-year-old steelmaker into a construction solutions powerhouse.
What Amazon, Apple, Microsoft, Meta, and Alphabet Just Told Investors
Angelo Zino, Senior Vice President and Technology Equity Research Analyst at CFRA, breaks down Big Tech earnings, AI spending, and what's next for the Mag 7.
How Phantom Space Plans to Disrupt the Commercial Space Race
Jim Cantrell, Co-Founder and CEO of Phantom Space, explains how the company is working to make rocket launches faster, cheaper, and more scalable.
Meta and Microsoft Just Sent a Big AI Message to Investors
Big Tech is pouring billions into AI. Ray Wang, CEO of Constellation Research, explains what Meta and Microsoft's earnings reveal about those investments.
